THE MEDIATOR OF CELLULAR IMMUNITY : II. MIGRATION OF IMMUNOLOGICALLY COMMITTED LYMPHOCYTES INTO INFLAMMATORY EXUDATES by Koster, F. T. et al.
THE  MEDIATOR  OF  CELLULAR  IMMUNITY 
II.  MIGRATION  OF  IM~UNOLOGICALLY  COMMITTED  LYMPHOCYTES  INTO 
INFLAMMATORY EXUDATES* 
BY F. T. KOSTER,:~ D. D. McGREGOR,§ M.D., AND G. B. MACKANESS, M.B. 
(From  the  Trudeau  Institute,  Saranac  Lake, New  York 12983) 
(Received  for  publication  23  September  1970) 
It was shown in the preceding paper  (1)  that rats  can be protected against 
Listeria monocytogenes  by a population of lymphocytes which is formed during 
infection with  this  organism.  The protective  cells  have  a  rapid  turnover  rate 
and enter the blood by way of the thoracic duct. It is not known what happens 
to  them  thereafter,  except  that  they  do  not  reenter  central  lymph  in  the 
manner of the majority of small lymphocytes present in the thoracic duct. 
The  disposition  and  ultimate  fate  of  the  protective  cells  has  not yet been 
established.  It may be  significant,  however,  that  newly formed lymphocytes, 
as  a  class,  are  especially  prone  to  escape  from  the  blood  into  the  inflamed 
peritoneal cavity (2).I The present study was undertaken to determine whether 
the lymphocytes formed in response to a  Listeria  infection  share  this  propen- 
sity  for  entering  areas  of  inflammation.  The  results  show  that  nonadhering 
cells of a peritoneal exudate are more effective than thoracic duct lymphocytes 
in  their  ability  to protect  against  Listeria  challenge.  Inflammation may thus 
be the process  involved in  the deployment of specifically committed lympho- 
cytes, giving them access to sites  of bacterial  implantation  where  their  ability 
to influence macrophage activity (3) would be most usefully employed. 
Materials and Methods 
GeneraL--The organisms, method of immunization, and assay for protection against Listeria 
monocytogenes were described in the preceding paper  (1). 
Animals.--Ylale  and female Lewis rats were used. Donors of cells weighed 160-230 g; the 
recipients weighed 60-90 g. 
Cydopkosphamide.2--In order to weaken their own response to L. monocytogenes, recipients 
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of either normal or Listeria-immune cells were given a single dose of cyclophosphamide (Cy) ~ 
48 hr before infection. The drug was dissolved in 0.85% sodium chloride and injected subcu- 
taneously in a dose equivalent to 200 mg/kg body weight. 
Preparation  of Cell Suspensions.--All cells used for adoptive immunization were obtained 
on the 7th day of a primary Listeria infection. Thoracic duct cells were obtained as previously 
described (1).  Spleen cells were expressed through a 60 mesh stainless steel sieve and filtered 
through a 4 cm column of acid-cleaned cotton wool (4). They were washed in 50 ml of Hanks' 
balanced salt solution (BSS) containing  1% fetal calf serum and were resuspended in fresh 
medium for injection.  The final cell suspension was heterogeneous, but contained only a few 
macrophages. Peritoneal exudate cells were obtained from animals injected intraperitoneally 
with 50/zg of killed bacteria or with 30 ml/kg body weight of a 12% sterile solution of sodium 
caseinate (Nutritional Biochemicals Corporation, Cleveland, Ohio). The former were prepared 
from full-grown liquid cultures of  L. monocytogenes or Staphylococcus  albus.  The  organisms 
were killed in 700-/0 v/v ethanol, washed twice in  0.85% sodium chloride, and  lyophilized. 
They were freshly resuspended for use at a concentration of 50/2g/ml in saline. 
Peritoneal exudates were harvested 72 hr after stimulation with casein or 24 hr after the 
injection of killed bacteria. The animals were exsanguinated by heart puncture, and injected 
through the linea alba with 20 ml of BSS containing 100 IU of heparin. Mter gentle massage 
the contents of the peritoneal cavity were recovered by aspiration through a midline incision, 
and fil,tered through several layers of surgical gauze. The cells were then centrifuged for 10 min 
at 500 g and washed once in tissue culture medium 199  (5) containing 1% fetal calf serum. 
Pellets that were grossly contaminated with red blood cells were discarded. 
Exudates induced by casein contained about 75% large mononuclear cells (macrophages and 
lymphocytes with a nuclear diameter >8/z), 15% small mononuclear cells (small lymphocytes 
and monocytes), and a  variable number of polymorphonuclear  (PMN)  leukocytes,  eosino- 
philes, and mast cells. The relative number of small mononuclear cells was increased by incu- 
bating the cells at 37°C  in beakers containing sterile cotton wool. After 1 hr the medium was 
decanted and the cotton gently washed with medium  199  to remove sedimented but non- 
adherent cells. Cell suspensions prepared in this manner were enriched about 3-fold in lympho- 
cyte-like cells. 
Exudates induced by killed microorganisms were used without further purification. They 
were much less cellular than were the casein exudates and contained an average of 67% large 
mononuclear ceils,  13% small mononuclear cells,  15~o PMN lenkocytes, 4e/~ mast cells,  and 
1% eosinophiles. 
Radioactive Labeling of Thoracic Duct Cells.--Thoracic  dt:ct cells were labeled radioactively 
by injecting prospective donors with tritiated thymidine (3H-thymidine) every 8 hr during the 
first 6 days of the immunizing infection. At each injection the rats received 0.34/zCi aH-thy- 
midine (3 Ci/mmole, New  England Nuclear Corp.,  Boston, Mass.)  per gram  body weight. 
Labeled cells were collected from the duct during the first 24 hr period after the last injection 
of 3H-thymidine. 
Measurement of Radioactivity.--Peritoneal  exudate cells were centrifuged from the medium 
and resuspended  in ice-cold 5%  trichloroacetic acid  (TCA).  The insoluble precipitate was 
washed 3 times in 10 ml volumes of cold TCA, then heated for 1 hr at 90°C  in 5 ml of TCA. 
1 ml of the hot extract was added to 10 ml of a dioxane scintillant containing 100 g of naphtha- 
lene and 5 g of diphenyloxazole per liter. Radioactivity, measured in a Beckman LS-100 liquid 
scintillation spectrometer, was corrected for background radioactivity and quenching. 
8Abbreviations  used  in  this paper:  BSS,  Hanks'  balanced salt solution;  Cy,  cyclophos- 
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D. 
RESULTS 
Adoptive  Immunization by  Cells from  Listeria-Infected  Donors.--Lymphoid 
cells from  rats  which  have  survived  an  infection  with  L.  monocytogenes can 
protect  normal recipients  against  a  Listeria  challenge  (1).  The  protection  is 
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FIG. 1.  Plots showing the difference in log protection obtained in the livers and spleens of 
rats given 200  mg/kg  of  cyclophosphamide  48 hr before intravenous injection of varying 
numbers of spleen cells (©  ©), thoracic duct cells (O  O), or casein-induced peritoneal 
exudate cells (&--A)  from 7 day Listeria-immune donors.  Protection is expressed as the 
difference in log-viable  Listeria  in the tissues of adoptively immunized rats and nonimmunized 
controls at 48 and 72 hr (marked 2d and 3d, respectively)  after intravenous challenge with 
7.8 X  10  4 to 3.4 X  10  5 L. monocytogenes. Means of 4 or 5. 
immediate, and is expressed even in animals that have received a  lethal dose of 
cyclophosphamide (Cy)  48  hr before challenge. The  results of several experi- 
ments  using  Cy-treated rats are combined in Fig. 1. They show a  comparison 
of  the  protection  afforded by varying numbers  of spleen  cells,  thoracic duct 
cells, or cells from casein-induced exudates. Protection is expressed as the dif- 
ference between the log viable counts found at 48  and 72  hr in the livers and 
spleens of adoptively immunized and nonimmunized animals. F. D. KOSTER,  D. D. McGREGOR,  AND  G. B. MACKANESS  403 
It will be seen from Fig. 1 that a given cell population provided protection 
in proportion to the number of ceils injected, but that the exudate cells were 
about four times more effective than thoracic duct cells,  and some eight times 
more effective than spleen ceils. It could be argued, however, that the heightened 
efficiency of exudate cells was  a  spurious effect resulting from the use of re- 
cipients who were unduly susceptible to infection because of cyclophosphamide. 
Since  the  latter  interferes  with  monocyte production  (Koster,  F.  D.,  and 
D. D.  McGregor, unpublished observations), the protection afforded by exu- 
date ceils could be due in part to the phagocytic ceils present in the exudates 
used as a source of committed lymphocytes. This possibility was examined in 
the following experiment. 
The  Protective Capacity  of Exudate Cells from Normal and Listeria-Infected 
Donors.--Cy-treated rats were injected intravenously with cells obtained from 
exudates raised in either normal or Listeria-infected  donors. The exudates were 
induced by injecting 50/~g of alcohol-killed L. monocytogenes or S. albus into 
the  peritoneal cavity 24 hr before cell harvest. The cells from the  exudates 
were transferred to recipients in a dose equivalent to 106 cells per gram body 
weight.  They were injected intravenously 1 hr  after the  recipient had been 
challenged by the same route with 1.4 X  105 living L. monocytogenes. 
Fig. 2 indicates that exudate cells from normal, uninfected donors were un- 
able to influence the course of the challenge infection, whereas cells from the 
peritoneal  cavities  of  infected  donors  which  had  been  injected  with  killed 
L.  monocytogenes or killed S.  albus conferred substantial  and  approximately 
equal protection upon the livers and spleens of normal recipients. The mere 
transfer  of  phagocytic  cells  could  not  therefore  account for  the  protective 
effects produced with cells from immune donors. 
The Origin of the Protective Cells in Exudates.--Since  the cells which convey 
antimicrobial protection are absent from peritoneal exudates induced in normal 
animals, they must belong to a cell population that is recruited from the blood 
into the peritoneal cavities of Listeria-infected  donors only. The failure of the 
protective cells to adhere to glass or cotton serves to distinguish them from the 
macrophages which are an abundant constituent  of most  inflammatory exu- 
dates. If it could be shown, however, that the thoracic duct cells which label 
in the  course of a  Listeria infection can enter in substantial numbers into a 
peritoneal exudate after intravenous  transfer  to normal recipients,  it  would 
imply that the protective ceils are not only lymphocytes, but also that they 
belong to the population which reaches the blood from central lymph. The fol- 
lowing experiment was addressed to this question. 
Normal rats were injected repeatedly with 3H-thymidine during the first 6 
days of a primary Listeria infection in order to label newly formed lymphocytes 
including  those  which  convey  antimicrobial  protection  (1).  Cells  obtained 
from the thoracic duct on the  7th day of the immunizing infection were in- 404  THE  MEDIATOR  O]F CELLULAR  IM2~UNITY.  II 
jected  intravenously  into  normal  recipients.  Immediately  thereafter  the  re- 
cipients were  injected intraperitoneally with 50 ~g of killed L.  monocytogenes 
or killed S. albus. In each case,  a  continuous intravenous infusion of Ringer's 
solution was  given  to  the recipients. It contained  a  daily dose  of  1.2  mg  of 
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FIG. 2.  Curves showing the growth of L. monocytogenes in the livers and spleens of rats 
given  200  mg/kg  of cyclophosphamide  48 hr before intravenous injection of 10 ~ peritoneal 
exudate cells per gram of body weight. Uninjected controls (Q--O),  recipients of cells from 
normal unimmunized  animals  (O  (D), recipients of cells from  Listeria-immune donors 
stimulated with killed L. monocytogenes (A  i),  recipients of ceils from donors stimulated 
with killed S. albus (A----A). Means of 4. 
nonradioactive thymidine (6)  to minimize reutilization of radioactive residues 
released  from  labeled  donor  cells. 
The results of two experiments have been pooled in Fig. 3 where the flow of 
labeled donor lymphocytes from the blood into the inflamed peritoneal cavity 
is  expressed  as  the  concentration  of  radioactivity in  the  TCA-insoluble cell 
fraction of exudates harvested from individual recipients. Considerable varia- 
tion  was  observed  in  the  concentration  of  radioactivity found  at  each  time F.  D.  KOSTER~ D.  D.  MCGREGOR~ AND  G,  B.  MACKANESS  405 
interval,  but within each experiment the radioactivity in exudates  induced by 
L.  monocytogenes  increased  to  a  maximum at  24 hr.  At this  time  it exceeded 
the  level of radioactivity in  exudates  obtained from  rats  stimulated  with  S. 
albus.  The types of lymphocytes and factors influencing their  accumulation in 
inflammatory exudates  are examined in another report.  1 
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FIG. 3.  Plots showing the  concentration  of cell radioactivity in peritoneal  exudates  at 
varying intervals after their induction with either killed L. rnonocytogenes (0) or killed S. albus 
(O). Immediately before exudate induction, the animals were injected intravenously with 106 
thoracic duct cells per gram of body  weight. The donor cells were obtained from 7 day Listeria- 
immune rats which had been given repeated injections of 3H-thymidine (see text). Each point 
represents one recipient. 
The Protective  Elficiency  of Resident and Exudative Cells .from  the :Peritoneal 
Cavities  of Listeria-Infeeted Donors.--The foregoing experiment  indicates  that 
lymphocytes generated  during  a  Listeria infection have the capacity to move 
from the blood into the inflamed peritoneal  cavity, but they do not establish 
that  the  protective  cells  are present  in  the  peritoneum  as  an  especial  conse- 
quence  of  inflammation.  Peritoneal  exudate  cells  from  animals  stimulated 
with  killed L.  monocytogenes  and  cells resident  in  the  otherwise  unstimulated 
peritoneal  cavities  of  Listeria-infected  donors  were  therefore  compared  with 
respect to their abilities to inhibit the growth of Listeria in Cy-treated recipients. 
The cells were injected intravenously in varying numbers  1 hr after an  intra- 406  THE  MEDIATOR  OF  CELLULAR  IMMUNITY.  II 
venous challenge with L. monocytogenes (1.7  X  105-1.1  X  106). The results are 
expressed in Fig. 4 as the difference between the log viable Listeria in the livers 
and  spleens  of adoptively immunized  rats  and  nonimmunized  controls  sacri- 
ficed at 24 and 48 hr after challenge. It is  apparent  that  107 exudate cells per 
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FIG. 4.  Curves showing the protection obtained in the livers and spleens of rats given 200 
mg/kg of cyclophosphamide 48 hr before an intravenous injection of varying numbers of cells 
obtained  from the peritoneal  cavities  of Listeria-immune donors  (see text).  Protection  in 
animals given 106 exudate cells/gram body weight (O  0); protection in animals given 105 
exudate cells/gram  body weight  (O--O);  protection  in animals given 106 resident ceils/ 
gram body weight (A--A);  protection  in animals given 5 X  105 resident cells/gram body 
weight (A--A).  Means of 4. 
100  g  body  weight  (less  than  20%  of  cells  from  any  one  donor)  conferred 
substantially  more protection  than did 10  times  as many cells from the peri- 
toneal cavities of five equally immune, but unstimulated donors. It seems, there- 
fore, that the protective cells have little tendency to leave the circulation except 
in the presence  of inflammation. 
DISCUSSION 
The present studies substantiate  the observations of an accompanying report 
which showed that  thoracic duct cells  from Listeria-infected rats  can protect F.  D.  KOSTER,  D.  D.  McGREGOR,  AND  G.  B.  MACKANESS  407 
normal recipients against an intravenous Listeria challenge. They go further, 
however, in demonstrating that the protective cells, after delivery to the blood, 
can be recovered from inflammatory exudates in a fully functional condition. 
A radioautographic study of the distribution of radioactively labeled thoracic 
duct cells has also shown that newly formed lymphocytes of Listeria-infected 
rats can accumulate in inflammatory exudates raised in the peritoneal cavity.  1 
The selection process was found to be highly selective in that long-lived small 
lymphocytes, the major cellular constituents of the  thoracic duct,  were vir- 
tually excluded. It would seem,  therefore, that the newly formed small lym- 
phocytes which appear in greatly increased numbers in the central lymph of 
infected  animals  are  functionally similar  to  those  normally present  (2),  at 
least with respect to their affinity for the endothelium of inflamed blood vessels. 
The  movement  of  newly  formed  small  lymphocytes  into  inflammatory 
exudates could go far in explaining the circulation dynamics of the protective 
cells which  are  generated in  the  course of  an  acute Listeria  infection.  Since 
committed lymphocytes of the kind which enter the blood by way of the tho- 
racic duct do not reenter lymph after they have been injected intravenously (1), 
they are presumed to have a short circulating life-span. This may be due to the 
ease with which  they are  deflected from circulation to participate in  events 
such  as those used in  the present experiments to encourage committed lym- 
phocytes to accumulate in peritoneal exudates. The disposition of the protec- 
tive cells in the absence of induced inflammation has not yet been determined. 
It is possible that they live out their life-span in the blood and are removed as 
effete cells. Alternatively, they could exit from the circulation, possibly into the 
skin or the intestinal wall, where local conditions induce them to leave the blood. 
Indeed, the presence of small lymphocytes in peripheral lymph which has yet 
to pass through a lymph node implies that there is a small scale circulation of 
cells through a variety of tissues (7, 8) ; but the category of lymphocytes which 
engage in this peripheral circulation has yet to be determined. 
The ability of protective cells to emerge from the blood into an inflammatory 
exudate points to an important functional property which  ensures  that  cells 
of this type participate in inflammatory processes regardless of their immuno- 
logical specificity. The present study demonstrated that killed Listeria,  killed 
Staphylococci,  and  sodium  caseinate  all  were  effective  in  causing  Listeria- 
committed lymphocytes to accumulate in the peritoneal cavity. Other investi- 
gators have also  emphasized that  newly formed mononuclear cells  (lympho- 
cytes  and  monocytes)  ~ssemble  in  delayed  hypersensitivity  reaction  sites 
(9-12)  and skin  allografts  (13)  for reasons that  cannot be ascribed  to  their 
immunological  commitment.  The  observations  of  Prendergast  (13)  are  par- 
ticularly pertinent in that  cells labeled with 3H-thymidine in  a  lymph node 
draining a skin allograft found their way in equal numbers into two reference 
grafts, one of which was different from, and the other identical with, the graft 
used to provoke the immune response. Clearly, a population of rapidly l~beling 408  THE  MEDIATOR  OF CELLULAR  IMI~IUNITY.  II 
cells had been generated in the draining lymph node, became distributed sys- 
temically, and were available to enter rejecting skin grafts. They displayed their 
lack  of immunological purpose by arriving in equal numbers  in specific and 
nonspecific targets. 
The affinity of newly formed lymphocytes for inflamed tissue assumes im- 
portance when one considers their established role in resistance to infectious 
disease. It would be an enlightened mechanism that ensured the local presence 
of immunologically committed cells of all available specificities at sites threat- 
ened by bacterial invasion.  The fact that  mild  irritation results  in vascular 
changes  which  promote the  escape of short-lived lymphocytes, regardless  of 
their immunological leaning, explains the accelerated version of a delayed-type 
hypersensitivity reaction described by Hill (14). It occurs when specific antigen 
is injected into a site which has been prepared by the previous injection of a 
nonspecific inflammatory agent. The reaction at a prepared site evolves more 
rapidly and is more intense than normal. Hill concluded that an inflammatory 
stimulus, regardless of its nature, recruits the full spectrum of the host's cell- 
mediated sensitivities. The present findings seem to confirm this view. 
The ability of immunologically committed lymphocytes to assemble at sites 
of bacterial implantation may be crucial in  the case of infections caused by 
facultative intracellular parasites where host resistance rests ultimately upon 
the microbicidal properties of the infected animal's mononuclear phagocytes 
(3).  The latter  become functionally activated  through  an  immunological re- 
sponse in which specifically committed lymphocytes have a  decisive role. Al- 
though  the  mechanism  underlying  the  activation  process has  not  yet  been 
determined,  there  are  good reasons for thinking  that  intermediary products 
such as the migration-inhibitory factor (15) have a part to play. The admixture 
of committed lymphocytes and macrophages in inflammatory exudates would 
tend to favor their interaction and ensure that macrophages become activated 
in the very locations where they must exercise their protective function. 
SUMMARY 
Peritoneal  exudates  from  rats  which  have  survived  an  infection with  L. 
monocylogenes  can  protect  cyclophosphamide-treated  recipients  against  a 
Listeria  challenge. They are more effective in this respect than cells obtained 
from the spleen or thoracic duct lymph. Since exudate cells from normal rats 
and inocula prepared from the resident peritoneal cell populations of infected 
donors are unable to inhibit the challenge infection, the protective cells must 
belong to a  class of lymphocytes that emerges from the blood in response to 
inflammation. It is significant therefore that thoracic duct lymphocytes formed 
during an acute L#leria infection can move into exudates induced by a variety 
of inflammatory stimuli. The affinity of newly formed lymphocytes for inflamed 
tissue points to a mechanism whereby the host marshalls its cellular defenses F.  D.  KOSTER,  D.  D.  McGREGOR,  AND  G.  B.  MACKANESS  409 
at sites of bacterial invasion. The tendency of short-lived lymphocytes to leave 
inflamed vessels might also explain their short-circulating life-span. 
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